Biofrontera Inc. (BFRI)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.12
-0.88%
Mkt Cap $9.60M
No analyst coverage available
We don't have analyst ratings or price target data for Biofrontera Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.